Jones Aranthan II 4
4 · Vanda Pharmaceuticals Inc. · Filed Feb 28, 2020
Insider Transaction Report
Form 4
Jones Aranthan II
Chief Corp. Affairs Officer
Transactions
- Award
Common Stock
2020-02-26+30,000→ 90,000 total - Award
Employee Stock Option (Right to Buy)
2020-02-26+70,000→ 70,000 totalExercise: $11.32Exp: 2030-02-25→ Common Stock (70,000 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2021, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
- [F2]The option vests with respect to 25% of the underlying shares on February 26, 2021, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.